PL2179732T3 - Kompozycja farmaceutyczna łącząca środek hamujący enzym reduktazę HMG-CoA i środek hamujący enzymy lipazy żołądkowo-jelitowe - Google Patents

Kompozycja farmaceutyczna łącząca środek hamujący enzym reduktazę HMG-CoA i środek hamujący enzymy lipazy żołądkowo-jelitowe

Info

Publication number
PL2179732T3
PL2179732T3 PL08778967T PL08778967T PL2179732T3 PL 2179732 T3 PL2179732 T3 PL 2179732T3 PL 08778967 T PL08778967 T PL 08778967T PL 08778967 T PL08778967 T PL 08778967T PL 2179732 T3 PL2179732 T3 PL 2179732T3
Authority
PL
Poland
Prior art keywords
inhibiting agent
enzyme
pharmaceutical composition
coa reductase
composition combining
Prior art date
Application number
PL08778967T
Other languages
English (en)
Inventor
Armenta María Elena García
Murillo Josefina Santos
Ochoa Víctor Guillermo Alvarez
Original Assignee
Representaciones E Investig Medicas S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Representaciones E Investig Medicas S A De C V filed Critical Representaciones E Investig Medicas S A De C V
Publication of PL2179732T3 publication Critical patent/PL2179732T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL08778967T 2007-06-15 2008-06-16 Kompozycja farmaceutyczna łącząca środek hamujący enzym reduktazę HMG-CoA i środek hamujący enzymy lipazy żołądkowo-jelitowe PL2179732T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MX2007007283A MX2007007283A (es) 2007-06-15 2007-06-15 Composicion farmaceutica que comprende la combinacion de un agente inhibidor de la enzima hmg-coa reductasa y un agente inhibidor de la enzima lipasa gastrointestinal.
EP08778967.3A EP2179732B1 (en) 2007-06-15 2008-06-16 Pharmaceutical composition combining an enzyme hmg-coa reductase inhibiting agent and a gastrointestinal lipase enzyme inhibiting agent
PCT/MX2008/000077 WO2008153374A1 (es) 2007-06-15 2008-06-16 Composición farmacéutica que comprende la combinación de un agente inhibidor de la enzima hmg-coa reductasa y un agente inhibidor de la enzima lipasa gastrointestinal

Publications (1)

Publication Number Publication Date
PL2179732T3 true PL2179732T3 (pl) 2014-10-31

Family

ID=40129898

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08778967T PL2179732T3 (pl) 2007-06-15 2008-06-16 Kompozycja farmaceutyczna łącząca środek hamujący enzym reduktazę HMG-CoA i środek hamujący enzymy lipazy żołądkowo-jelitowe

Country Status (11)

Country Link
EP (1) EP2179732B1 (pl)
AR (1) AR067038A1 (pl)
BR (1) BRPI0813174A2 (pl)
CO (1) CO6241106A2 (pl)
CY (1) CY1115453T1 (pl)
EC (1) ECSP099801A (pl)
ES (1) ES2492665T3 (pl)
GT (1) GT200900316A (pl)
MX (1) MX2007007283A (pl)
PL (1) PL2179732T3 (pl)
WO (1) WO2008153374A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110314232A (zh) * 2019-08-03 2019-10-11 黄泳华 由脂肪酶抑制剂与羟甲戊二酰辅酶a还原酶抑制剂构成的组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005000217A2 (en) * 2003-06-06 2005-01-06 Merck & Co., Inc. Combination therapy for the treatment of dyslipidemia
WO2006109170A2 (en) * 2005-04-14 2006-10-19 Esperion Therapeutics Inc. Combination therapy for treatment of cardiovascular diseases and related conditions
MXPA06010973A (es) * 2006-09-25 2009-02-18 World Trade Imp Export Wtie Ag Composicion farmaceutica para el tratamiento del sobrepeso y la obesidad que se acompañan la dislipidemia.

Also Published As

Publication number Publication date
BRPI0813174A2 (pt) 2014-12-23
MX2007007283A (es) 2009-02-18
ECSP099801A (es) 2010-01-29
WO2008153374A8 (es) 2010-02-04
CY1115453T1 (el) 2017-01-04
EP2179732A1 (en) 2010-04-28
ES2492665T3 (es) 2014-09-10
EP2179732B1 (en) 2014-05-14
CO6241106A2 (es) 2011-01-20
EP2179732A4 (en) 2010-08-25
WO2008153374A1 (es) 2008-12-18
AR067038A1 (es) 2009-09-30
GT200900316A (es) 2011-07-25

Similar Documents

Publication Publication Date Title
IL198349A0 (en) Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors
GB0619753D0 (en) Enzyme inhibitors
ZA200903598B (en) Lipase variants for pharmaceutical use
ZA200802369B (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
EP2056835A4 (en) PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
IL194339A0 (en) Enzyme inhibitors
IL190714A0 (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
IL197190A0 (en) Combined pharmaceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors
HK1136160A1 (en) Disintegrin variants and pharmaceutical uses thereof
EP2180891A4 (en) COMBINATION PREPARATION WITH HMG COA REDUCTASE INHIBITORS AND ASPIRIN AND METHOD FOR THE PRODUCTION THEREOF
IL196251A0 (en) Soluble epoxide hydrolase inhibitors
EP2086999A4 (en) INHIBITORS FOR INTERRUPTING THE INTERACTION OF ENZYMES ASSOCIATED WITH UBIQUITINYLATION AND USES THEREOF
GB0608821D0 (en) DHFR enzyme inhibitors
AU2007260950A8 (en) Methods and compositions for targeting HEPSIN
IL193469A0 (en) Novel lipases and uses thereof
PL2252282T3 (pl) Kompozycja kosmetyczna i/lub dermatologiczna zawierająca inhibitor reduktazy hmg-coa i inhibitor syntazy pirofosforanu farnezylu
IL187728A0 (en) Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors
IL187730A0 (en) Azolopyridine-2-on derivatives as lipase and phospholipase inhibitors
EP2070919A4 (en) SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION
IL187729A0 (en) Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors
GB0608844D0 (en) Enzyme inhibitors
EP1871396A4 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS WITH AN HMG COA REDUCTASE INHIBITOR
EP2049102A4 (en) POLYMORPHIC FORMS OF AN HMG COA REDUCTASE HEATHER AND USE
GB0617161D0 (en) Enzyme inhibitors
HK1081843A1 (en) Pharmaceutical composition comprising reductase inhibitor hmg-coa and melatonin